RJA
BIND

Raymond James & Associates’s BIND THERAPEUTICS INC BIND Stock Holding History

Raymond James & Associates’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-32,100
Closed -$276K – 2401
2014
Q3 		$276K Sell
32,100
-6,240
-16% -$61.5K ﹤0.01% 2067
2014
Q2 		$505K Buy
38,340
+5,550
+17% +$54.3K ﹤0.01% 1841
2014
Q1 		$392K Sell
32,790
-660
-2% -$8.62K ﹤0.01% 1880
2013
Q4 		$505K Buy
+33,450
New +$426K ﹤0.01% 1670

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Raymond James & Associates's BIND Position: Q4 2014 in Review

Raymond James & Associates sold out of BIND THERAPEUTICS INC (BIND) in Q4 2014, closing a stake of 32,100 shares — an estimated $276K sold.

Raymond James & Associates first reported a position in BIND in Q4 2013 and held it in 4 quarters. The position peaked at $505K in Q2 2014. 37 funds tracked by Wall St. Rank hold BIND as of Q4 2014.

  • Raymond James & Associates reported no remaining BIND THERAPEUTICS INC position as of Q4 2014 after selling out during the quarter.
  • Raymond James & Associates sold 32,100 BIND THERAPEUTICS INC shares in Q4 2014, an estimated $276K.
  • Raymond James & Associates first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 4 quarters.
  • Raymond James & Associates's BIND THERAPEUTICS INC position peaked at $505K in Q2 2014.
  • 37 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q4 2014.

Based on Raymond James & Associates's 13F filing for Q4 2014, filed 11 Feb 2015.